Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Specimen Handling 149pembrolizumab 130Magnetic Resonance Spectroscopy 120Cyclophosphamide 117Biopsy 102fludarabine 89Nivolumab 58Carboplatin 53Cisplatin 48Radiotherapy 46Gemcitabine 46venetoclax 43Paclitaxel 41Cetuximab 41fludarabine phosphate 39Ipilimumab 35atezolizumab 34Fluorouracil 34Bevacizumab 33durvalumab 29Radiation 28Oxaliplatin 28Leucovorin 28Dexamethasone 28X-Rays 26Irinotecan 26Cytarabine 26Azacitidine 26Radiosurgery 24Injections 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Multiparametric Magnetic Resonance Imaging × 90 days × Clear all
NCT03388619 2026-05-27

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡